Melanoma March is around the corner
2 February 2015
Our fourth annual Melanoma March is fast approaching and with 23 marches happening all over Australia; it is almost time to march for a cure and help us raise over $1 million for vital melanoma research.
Thanks to everyone who has already registered to march in 2015 and has been fundraising to help us reach our goal. Imagine what $1 million could do for melanoma research.
Melanoma March will officially launch with its first marches happening on the 22nd February and continue throughout the month of March with people getting involved all around the country. If you register before the 20th February, you will go into a draw to win a $500 fuel voucher.
You can also help raise money by buying a raffle ticket for only $10 for your chance to win a Toyota Yaris.
Sunday, 22 February 2015 - Melbourne
Sunday, 22 February 2015 -Wollongong
Saturday, 28 February 2015 - Bribie Island
Sunday, 8 March 2015 - Bunbury
Sunday, 15 March 2015 - Canberra
Saturday, 21 March 2015 -Gosford
Saturday, 21 March 2015 - Taree
Sunday, 22 March 2015 - Adelaide
Sunday, 22 March 2015 - Bathurst
Sunday, 22 March 2015 - Bonny Hills
Sunday, 22 March 2015 - Brisbane
Sunday, 22 March 2015 - Cairns
Sunday, 22 March 2015 - Coolangatta
Sunday, 22 March 2015 - Darwin
Sunday, 22 March 2015 - Perth
Sunday, 22 March 2015 - Manly
Sunday, 22 March 2015 - Rockingham
Sunday, 22 March 2015 - Townsville
Sunday, 22 March 2015 - Wagga Wagga
Sunday, 22 March 2015 - Perth
Sunday, 29 March 2015 - Busselton
Sunday, 29 March 2015 - Karratha
Sunday, 29 March 2015 - Picton
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.